Vascular Disease Topics

The On-Topic Netowork

Vascular Disease > Coronary Artery Disease


Coronary Artery Disease
Coronary Artery Disease
Coronary Artery Disease
Coronary Artery Disease
Coronary Artery Disease

The following information is about Coronary Artery Disease.

Coronary Artery Disease Defined

Usually caused by artherosclerosis, a progressive condition which reduces blood flow to the heart.

This definition is in context to Vascular Disease. See more contextual defintions for Coronary Artery Disease.


Navigation: [ 1 2 3 Next ]

At any age, it makes sense to keep yourself in balance

Published September 7, 2008, 11:24 pm, The Times-News

There are times in your life when feeling a little off-balance may actually be a good thing. Take it from the experts.

Full Story


Principal Proposed Natural Treatments

Published September 6, 2008, 9:55 pm, ThirdAge

The herb stevia is best known as a sweetener. Its active ingredients are known as steviosides.

Full Story


YourHealth: Know your arteries for a healthier heart

Published September 6, 2008, 5:48 pm, The New Straits Times

THIS month, the World Heart Federation will be celebrating World Heart Day 2008 with the theme “Know Your Risk".

Full Story


NIMS' Acceleration Therapeutic Platform: Potential Non-Invasive Home Treatment Of Coronary Artery Disease

Published September 6, 2008, 2:14 pm, Medical News Today

Marvin A Sackner, M.D., CEO, Chairman of the Board, Non-Invasive Monitoring Systems, Inc.

Full Story


CYPHER® Sirolimus-eluting Coronary Stent Comparable To Bypass Surgery In Key Safety Measures In Patients With Diabetes ...

Published September 6, 2008, 12:14 pm, Medical News Today

Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes.

Full Story


Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is ...

Published September 4, 2008, 11:00 am, Business Wire via Yahoo! Finance

MUNICH----Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery in key safety endpoints in patients with multi-vessel disease and diabetes.

Full Story


Heart op numbers collapse in Auckland

Published September 3, 2008, 9:59 am, The New Zealand Herald

The number of heart operations in Auckland has collapsed by a fifth since the nation's leading cardiac hospital shifted premises.

Full Story


ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer

Published September 3, 2008, 9:24 am, Centre Daily Times

ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The application, submitted on August 29, 2008, was prepared in conjunction ...

Full Story


ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer

Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance

NEW YORK----ImClone Systems Incorporated today announced that it has submitted an application to the U.S. Food and Drug Administration to broaden the use of ERBITUX® to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck .

Full Story


Stentys Appoints Rene Spaargaren, MD, as Chief Medical Officer

Published September 3, 2008, 7:09 am, Centre Daily Times

Stentys (http://www.stentys.com) announced today that it has appointed Dr. Rene Spaargaren as its Chief Medical Officer (CMO). Stentys is developing the world's first next-generation drug-eluting stent for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery.

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Vascular Disease > Coronary Artery Disease news? Try our new "Coronary Artery Disease News Focus" area.

Off-site Coronary Artery Disease Links, User Submitted

The following links have been collected through user bookmark submission in the Coronary Artery Disease category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Aug 28

Wed Aug 20

Tue Aug 19

Mon Aug 18

Fri Aug 15

Thu Aug 14

Tue Aug 12

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Coronary Artery Disease. If you would like to find related tags we recommend Tag Patterns > Coronary Artery Disease

Off-site Coronary Artery Disease Research Links

If you still need additional information on Coronary Artery Disease then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Vascular Disease

If you know the Vascular Disease Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Vascular-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a